Antibacterial activity and mechanism of berberine against Streptococcus agalactiae

International Journal of Clinical and Experimental Pathology

Volumn 8, Issue 5, 2015, Pages 5217-5223

  Peng, Lianci ^a   Kang, Shuai ^a   Yin, Zhongqiong ^a   Jia, Renyong ^a   Song, Xu ^a   Li, Li ^a   Li, Zhengwen ^a   Zou, Yuanfeng ^a   Liang, Xiaoxia ^a   Li, Lixia ^a   He, Changliang ^a   Ye, Gang ^a   Yin, Lizi ^a   Shi, Fei ^a   Lv, Cheng ^a   Jing, Bo ^a  

^a SICHUAN AGRICULTURAL UNIVERSITY   (China)

Author keywords

Antibacterial activity; Berberine; SDS PAGE; Streptococcus agalactiae; TEM

Indexed keywords

ANTIINFECTIVE AGENT; BACTERIAL DNA; BACTERIAL PROTEIN; BERBERINE;

BIOSYNTHESIS; CELL MEMBRANE; DNA REPLICATION; DOSE RESPONSE; DRUG EFFECTS; FLUORESCENCE MICROSCOPY; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIAL VIABILITY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROCEDURES; PROTEIN SYNTHESIS; PROTEOMICS; STREPTOCOCCUS AGALACTIAE; TIME FACTOR; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BERBERINE; CELL MEMBRANE; DNA REPLICATION; DNA, BACTERIAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHORESIS, POLYACRYLAMIDE GEL; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; MICROSCOPY, ELECTRON, TRANSMISSION; MICROSCOPY, FLUORESCENCE; PROTEIN BIOSYNTHESIS; PROTEOMICS; STREPTOCOCCUS AGALACTIAE; TIME FACTORS;

EID: 84937784115     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Brochet M, Couve E, Zouine M, Vallaeys T, Rusniok C, Lamy MC, Buchrieser C, Trieu-Cuot P, Kunst F, Poyart C, Glaser P. Genomic diversity and evolution within the species Streptococcus agalactiae. Microbes Infect 2006; 8: 1227-1243.
2. Sorensen UB, Poulsen K, Ghezzo C, Margarit I, Kilian M. Emergence and global dissemination of host-specific Streptococcus agalactiae clones. mBio 2010; 1: 1-9.
3. Schuchat A. Epidemiology of group streptococcal disease in the United States: shifting paradigms. Clin Microbiol Rev 1998; 11: 497-513.
4. Nizet V and Rubens CE. Pathogenic mechanisms and virulence factors of group B streptococci. Gram-positive pathogens. In: Nizet V, Rubens CE. editors. Washington: DC; 2000. pp. 125-136.
5. Farley MM. Group B streptococcal disease in non-pregnant adults. Clin Infect Dis 2001; 33: 556-561.
6. Zewdu E, Cornelius P. Antimicrobial resistance pattern of Salmonella serotypes isolated from food items and personnel in Addis Ababa, Ethiopia. Trop Anim Health Prod 2009; 41: 241-249.
7. Haydon DJ, Stokes NR, Ure R, Galbraith G, Bennett JM, Brown DR Baker PJ, Barynin VV, Rice DW, Sedelnikova SE, Heal JR Sheridan JM, Aiwale ST, Chauhan PK, Srivastava A, Taneja A, Collins I, Errington J, Czaplewski LG. An inhibitor of FtsZ with potent and selective anti-staphylococcal activity. Science 2008; 321: 1673-1675.
8. Sommer MOA, Dantas G, Church GM. Functional characterization of the antibiotic resistance reservoir in the human microflora. Science 2009; 325: 1128-1131.
9. Zlitni S, Brown ED. Drug discovery: Not as fab as we thought. Nature 2009; 458: 39-40.
10. Peng LC, Yin ZQ, Jia RY, Li L, Dai RY, Qu J, Liu MH, Chen P. Effects of twenty traditional Chinese medicine extracts against Strep-tococcus agalactiae in vitro. Journal of South China Agricul 2014; 35: 22-25.
11. Yang Y, Ye XL, Li XG, Zhen LS. Anti-microbial effect of four alkaloids from Coptidis rhizoma. Med Mater Med Res 2007; 18: 3013-3014.
12. Braissant O, Wirz D, Göpfert B, Daniels AU. Use of isothermal microcalorimetry to monitor microbial activities. FEMS Microbiol Lett 2010; 303: 1-8.
13. Ikram M. A review on the chemical and pharmacological aspect of genus Berberis. Planta Med 1975; 28: 353-358.
14. Huang KC, Williams WM. Antibacterial, antiviral, and antifungal herbs. The pharmacology of Chinese Herbs. New York. NY: CRC Press; 1999. pp. 381-383.
15. Kuo CL, Chi CW, Liu TY. The anti-inflammatory potential of berberine in vitro and in vivo. Cancer Lett 2004; 203: 127-137.
16. Choi BH, Ahn IS, Kim YH, Park JW, Lee SY, Hyun CK, Do MS. Berberine reduces the expressing of adipogenic enzymes and inflammatory molecules of 3T3-L1 adipocyte. Exp Mol Med 2006; 38: 599-605.
17. Yi ZB, Yan Y, Liang YZ, Bao Zeng. Evaluation of the antimicrobial mode of berberine by LC/ESI-MS combined with principal component analysis. J Pharm Biomed Anal 2007; 44: 301-304.
18. Yan D, Jin C, Xiao XH, Dong XP. Antimicrobial properties of berberines alkaloids in Coptis chinensis Franch by microcalorimetry. J Biochem Biophys Methods 2008; 70: 845-849.
19. Hayashi K, Minoda K, Nagaoka Y, Hayashi T, Uesato S. Antiviral activity of berberine and related compounds against human cytomegalovirus. Bioorg Med Chem Lett 2007; 17: 1562-1564.
20. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing, PA. Ninth International Supplement 2008; M100-S9.
21. Liu YF, Luan C, Xia X, An S, Wang Y. Antibacterial Activity, Cytotoxicity and Mechanisms of action of Cathelicidin Peptides against Enteric Pathogens in Weaning Piglets. Int J Pept Res Ther 2011; 17: 175-184.
22. Tao C, Wei Q, Yin ZQ. Antifungal activity of the essential oil from Cinnamomum longepaniculatum leaves against three species of fungi. Chin Vet Sci 2011; 41: 89-93.
23. Kong WJ, Xing XY, Xiao XH, Zhao YL, Wei JH, Wang JB, Yang RC, Yang MH. Effect of berberine on Escherichia coli, Bacillus subtilis, and their mixtures as determined by isothermal microcalorimetry. Appl Microbiol Biotechnol 2012; 96: 503-510.
24. Rasooli I, Rezaei MB, Allameh A. Growth inhibition and morphological alterations of Aspergillus niger by essential oils from Thymus eriocalyx and Thymus x-porlock. Food Control 2006; 17: 359-364.
25. Sangetha S, Zuraini Z, Suryani S, Sasidharan S. In situ TEM and SEM studies on the antimicrobial activity and prevention of Candida albicans biofilm by Cassia spectabilis extract. Micron 2009; 40: 439-443.
26. Sun J, Wu GJ. The mechanism of the antibacterial medicine. Chin J Vet Med 2007; 43: 42-43.
27. Walker JM. The protein protocols handbook. In: Walker JM. editor. Springer; 1996.
28. Jason JC and Ryden L. Protein Purfication: Principles, High Resolution Methods, and Applications. In: John Wiley Sons. editor. New York; 1998. pp. 463-493.
29. Brozel VS and Cloete TE. Bacterial resistance to conventional water treatment biocides. Biodeterior Abstracts 1993; 7: 387-393.
30. Cloete TE, Thantsha MS, Maluleke MR and Kirkpatrick R. The anti-microbial mechanism of electrochemically activated water against Pseudomonas aeruginosa and Escherichia coli as determined by SDS-PAGE analysis. J Appl Microbiol 2009; 107: 379-384.
31. Zinkevich V, Beech IB, Tapper R and Bogdarina I. The effect of super-oxidized water on Escherichia coli. J Hosp Infect 2000; 46: 153-156.
32. He F, Yang Y, Yang G, Yu LJ. Studies on antibacterial activity and antibacterial mechanism of a novel polysaccharide from Streptomyces virginia H03. Food Control 2010; 21: 1257-1262.
33. Yunman L, Haojie Z, Guoqing L. Shikonin Inhibiting the catalytic activity of DNA Topoisomerase I and inducing the apoptosis of K562 leukemia cells. Chin J Nat Med 2003; 1: 165-167.
34. Yang F, Chen Y, Duan W, Zhang C, Zhu H, Ding J. SH-7, a new synthesized shikonin de-rivative, exerting its potent antitumor activities as a topoisomerase inhibitor. Int J Cancer 2006; 119: 1184-1193.